BLACKSBURG, Va.–(BUSINESS WIRE)– #ACG2026–NImmune reports ACG 2026 data supporting omilancor and NIM-1324 in hard-to-treat IBD, highlighting LANCL2 and its TITAN-X AI platform.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.